简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-09-07 18:05 New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients
2021-09-06 19:48 PHC Holdings Corporation: Appointment of Mr. William Donnelly and Mr. Ivan Tornos as Independent External Directors
2021-09-03 18:24 Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use
2021-09-03 15:36 Morinaga Milk Reveals Major Breakthroughs in a ‘Bifidobacteria Training’ Program With Professional Footballer Yuto Nagatomo
2021-09-03 15:24 Patient Safety Movement Foundation Calls for Action in Advance of Second Annual #UniteForSafeCare Event
2021-09-02 19:00 Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
2021-09-02 15:59 AGIC Capital Announces Final Closing of US$1.2 Billion Fund for Investments in Smart Industries
2021-09-02 13:49 Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose
2021-08-31 20:44 Jamaica’s Manufacturing Sector to Play Strong Role in Economic Recovery
2021-08-31 15:00 Masimo SafetyNet Alert™ Launches in Western Europe
2021-08-31 13:42 Vifor Pharma’s Ferinject® granted new recommendations in updated 2021 ESC heart failure guidelines
2021-08-30 18:32 P&G Studios and Harder Than You Think Foster Game Changing Conversations in New Podcast Series “Equal Too: Achieving Disability Equality”
2021-08-30 14:54 Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
2021-08-30 09:43 Landmark trial demonstrates empagliflozin is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction
2021-08-27 12:28 Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19
2021-08-26 16:17 RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc.
2021-08-26 14:01 Noxopharm Phase I Clinical Trial Shows Anti-Inflammatory Response in COVID-19 Patients
2021-08-26 10:58 BridgeBio Pharma and LianBio Announce First Patient Treated in Phase 2a Trial of Infigratinib in Patients with Gastric Cancer and Other Advanced Solid Tumors
2021-08-25 14:42 Adjuvance Technologies Announces First Clinical Results of its Next-generation Saponin Adjuvant
2021-08-24 14:58 New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients

Business Wire Weibo

Press Releases

Latest Releases